is the fda going to ban compounded semaglutide "semaglutide" not FDA-approved FDA Warns on Certain Forms

Tracking progress from the starting dose What you track during the starting dose period forms the foundation for every dose adjustment decision you will make for the duration of your protocol

Along with the improvements in inflammation that occur due to weight loss and improved insulin sensitivity, GLPs appear to directly modulate the immune system by engaging receptors on immune cells

What that transparency doesn't do is eliminate the category-level considerations every buyer in this space needs to work through in mid-2026: compounded medications aren't FDA-approved, the regulatory environment governing their availability continues to evolve, and the right platform for you depends on your clinical eligibility, state-specific availability, your own health history, and your comfort level with a fully online clinical management model

doi: 10.1210/me.2014-1346 44